Reneo Pharmaceuticals
(NASDAQ) RPHM
Reneo Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$0.00
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RPHM News
RPHM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Reneo Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
45
CEO
Nicholas A. Saccomano, PhD
Website
onkuretherapeutics.comHeadquarters
Irvine, CA 92612, US
RPHM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$62.95M
EBITDA
$62.95M
Operating Cash Flow
$51.83M
Capital Expenditure
$46.00K
Free Cash Flow
$51.87M
Cash & ST Invst.
$59.05M
Total Debt
$549.00K
Reneo Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$0.00
-100.0%
EBITDA
$14.13M
-139.3%
Quarterly Fundamentals
Net Cash
$58.50M
-46.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$549.00K
+2.4%
Return on Assets
0.00%
N/A
Return on Invested Capital
-1.12%
N/A
Free Cash Flow
$11.52M
-222.9%
Operating Cash Flow
$11.51M
-224.9%